Abstract
PURPOSE:
Toxic anterior segment syndrome (TASS) is a noninfectious anterior chamber reaction caused by ocular surgeries. It usually develops within the first 12–48 h after surgery. In case of clinical suspicion of TASS, endophthalmitis as a devastating disease should always be excluded. However, the fact that TASS and endophthalmitis can look the same, but the treatment for each is different. Therefore, distinguishing between the two conditions is an important factor in coping with both diseases. It was aimed to describe the features and clinical management that are considered when distinguishing the cause of unexpected inflammatory response after cataract surgery.
METHODS:
A retrospective review of medical records of 13 patients who developed TASS in our clinic at Ege University Ophthalmology Department on three different days between July 2022 and December 2022 were included in this study. Anterior segment photographs of those 13 patients and the records of ophthalmological examinations of those patients, including best-corrected visual acuity (BCVA), ocular pressure, biomicroscopic, and fundoscopic examination, were collected. Medical data were evaluated retrospectively.
RESULTS:
The mean time to onset of clinical symptoms was 27.6 h. The main complaint was pain in nine patients. The primary symptom in the remainder of the patients was blurred vision. Severe hypopyon was seen in 5 cases. Despite the presence of pain and hypopyon, patients who were treated with topical steroids were closely followed up (every 2 h) because they were consecutive patients and had relatively acute onset complaints. Inflammation was regressed after an average of 4 h. No factor causing TASS was found. The BCVA was at the minimum level of 8/10 on the 5th day of surgery.
CONCLUSION:
When distinguishing TASS from endophthalmitis, severe pain, relatively late onset, hyperemia, and the presence of severe hypopyon usually lead ophthalmologists to the clinical diagnosis of endophthalmitis. However, in this study, most of the patients diagnosed with TASS had severe pain, a significant portion of them had hypopyon, and the onset of the symptoms was relatively late. Close follow-up immediately after suspicion plays a vital role in clinical diagnosis and management accordingly.
Keywords: Cataract surgery, endophthalmitis, hypopyon, ocular inflammation, toxic anterior segment syndrome
Introduction
Intense inflammation after cataract surgery is a clinical picture that ocular surgeons do not like to observe. We consider two main pathologies, endophthalmitis and toxic anterior segment syndrome (TASS), in line with the onset time, main complaints, and clinical findings when we encounter this rare condition.
TASS is a noninfectious postoperative inflammation with a good clinical course, most commonly occurring after cataract surgery.[1] It can occur in both sporadic and clustered outbreaks.[2] The incidence after cataract surgery is probably around 1 in 1000. Although its pathophysiology is unclear, TASS represents an inflammatory response to a substance typically used during surgery, such as an endotoxin-containing balanced salt solution, viscoelastic, and intracameral antibiotic.[2,3] Sometimes, a cause cannot be determined.
Acute postoperative endophthalmitis is a serious intraocular inflammatory disorder with a poor visual prognosis that causes infection in the vitreous cavity with direct inoculation of microorganisms. When these two clinical entities with significant inflammation are compared, there are differences in duration of onset, incidence in consecutive patients, and symptoms and signs.
However, the fact that TASS and endophthalmitis can look exactly the same, but the treatment for each is different, is an important problem in ophthalmology practice. Therefore, distinguishing between the two conditions is an important factor in coping with both diseases.
This study aimed to describe the features and clinical management that are taken into account when distinguishing the cause of unexpected inflammatory response after cataract surgery.
Methods
A total of 13 patients who developed TASS in our clinic on 3 different days between July 2022 and December 2022 were included in this study. Anterior segment photographs of those 13 patients and the records of ophthalmological examinations of those patients, including best-corrected visual acuity, ocular pressure, biomicroscopic, and fundoscopic examination, were collected. Medical data were evaluated retrospectively.
Results
A total of 13 cases diagnosed with TASS on 3 different days after cataract surgery were presented here. The cohort is composed of 7 male and 6 female patients with an average of 68.84 ± 11.34 years of age. Three-piece intraocular lens was used in each cataract surgery, and no other surgical complication was observed during these surgeries.
The mean time to onset of clinical symptoms was 27.6 h. All patients had complaints of blurred vision. However, the main complaint was pain in nine patients, while the rest of them complained of blurred vision primarily. Corneal edema was seen in all cases. One patient, who has macular degeneration preoperatively, presented with vitiritis at the time of TASS diagnosis. Severe hypopyon was seen in 5 cases. All patients were admitted to the hospital at the time of their initial complaint, and topical steroid administration was initiated. Topical dexamethasone 1 mg/1 mL (Maxidex %0.1 ophthalmic suspension) was administered hourly to each patient. In addition to topical treatment, 1 mg/kg methylprednisolone intravenous (IV) was given only to the patient who had vitiritis. Each patient was followed up every 2 h. Despite the presence of pain and hypopyon, patients who were treated with topical steroids were closely followed up because they were consecutive patients and had relatively acute onset complaints. Clinical characteristics of 13 TASS cases are shown in Table 1.
Table 1.
Clinical characteristics of the 13 toxic anterior segment syndrome cases
| Clinical manifestation | Ratio (%) |
|---|---|
| Hypopyon | 5/13 (38.5) |
| Pain | 9/13 (69.2) |
| Anterior vitreous opacity | 1/13 (7.6) |
| Corneal edema | 13/13 (100) |
| Chemozis | 0 |
| Anterior chamber fibrin reaction | 4/13 (30.7) |
In the follow-ups, the signs of inflammation regressed after an average of 4 h. Complete resolution of symptoms and signs was seen at the postoperative 40th to 48th h except for the patient with vitiritis. The complete resolution took 72 h for the patient with vitiritis who underwent both topical and IV steroid treatment. As a result of the evaluations, no factor causing TASS was found in the cases. Visual acuity was recovered at the minimum level of 0.8 on the 5th day of surgery except for one patient. The patient with preoperative macular degeneration had a final visual acuity of 0.05, which is equal to the preoperative visual assessment after complete recovery from TASS. Even the recovery took the longest in the patient with vitiritis, in the end, no resting complication due to TASS was observed in any case.
Figure 1 shows the clinical course of a TASS case with close follow-up intervals. The patient was admitted to the clinic at the postoperative 20th h with corneal edema and hypopyon and treatment was initiated accordingly [Figure 1a]. At the postoperative 24th h, hypopyon regressed [Figure 1b]. At the postoperative 40th h, corneal edema and hypopyon regressed totally [Figure 1c].
Figure 1.
The progression of a case of toxic anterior segment syndrome was observed at the 20th h after surgery (a), 24th h (b), and 48th h (c)
The clinical progression of presurgical macular degeneration in a patient is depicted in Figure 2. The patient presented with corneal edema and hypopyon, which were observed at the 24th h after surgery [Figure 2a]. To address these symptoms, the patient received topical corticosteroid treatment, which led to a decrease in edema and hypopyon by the 48th h [Figure 2b]. By the 72nd h, the edema and hypopyon had resolved completely [Figure 2c].
Figure 2.
The progression of a case of TASS with presurgical macular degeneration in a patient is depicted at the 24th h after surgery with corneal edema and hypopyon (a), a decrease in edema and hypopyon by the 48th after topical corticosteroid treatment (b), complete resolution of the edema and hypopyon by the 72nd h (c)
Discussion
Toxic intraocular syndrome (TIOS) is a comprehensive diagnosis that incorporates any form of postsurgical inflammatory reaction due to a noninfectious process.[4] TIOS can occur in any segment of the eye. TASS, fibrin syndrome, sterile endophthalmitis, and toxic posterior segment syndrome (TPSS) are the most commonly seen noninfectious inflammatory postsurgical reactions.
TPSS can present with typical posterior segment involvement signs and symptoms: changes in foveal retinal pigment epithelial changes in fundus examinations, floaters, photophobia, glares and halos, decrease in visual acuity, visual distortion, etc.[5] In literature, it is shown to be developed both after posterior segment surgeries with signs and symptoms of retinal vasculitis and a dropless cataract surgery.[5-7]
The overall incidence of TASS was shown to be 0.22% in a large case series.[8] Still, it is a more common entity compared to infectious endophthalmitis.[4] In literature, Feng et al. showed that only 26% of endophthalmitis cases are related to cataract surgery, and other causes comprise the rest: endogenous source (20%), intravitreal injection (17%), trabeculectomy (15%), corneal transplantation (8%), infectious keratitis (5%), open-globe injury (5%), glaucoma drainage device placement (4%), and pars plana vitrectomy (1%).[9]
The main distinguishing features between TASS and infectious endophthalmitis, which we refrain from encountering after cataract surgery and cause ocular inflammation, are the onset, speed of symptom progression, pain, and presence or absence of vitiritis.[10] However, both conditions may present with poor visual acuity, corneal inflammation, and significant anterior chamber reaction.
Cases of TASS usually develop within the first 12–48 h after surgery, while cases of endophthalmitis usually occur between days 3 and 10 postsurgery.[11,12] As an exception, endophthalmitis due to Bacillus cereus may occur within the first 18–24 h after surgery.[13] Therefore, although early onset of symptoms may lead to the diagnosis of TASS, it is not definitive in terms of diagnosis. In this study, the onset time was between 24 and 48 h and was detected in the relatively early period.
Although the presence of pain as a symptom is primarily in favor of endophthalmitis, pain may also accompany TASS cases. In this study, pain was the first symptom in 69.23% of the cases, which was different from what was expected.
As mentioned before, symptoms of endophthalmitis after cataract surgery occur within 1 week in 75% of cases, and hypopyon is present in >80% of them.[14] TASS is characterized by a sterile anterior chamber reaction. Any surgical instrument, sterilization material or solution used during the surgery can trigger this reaction, organic or nonorganic.[15] Sometimes the cause cannot be determined. In this study, hypopyon was evident in approximately 40% of the patients, and the factor that would trigger inflammation could not be detected in the evaluation.
TASS represents an inflammatory response to a substance that is typically used during surgery, such as a balanced salt solution containing endotoxin, viscoelastic, and intracameral antibiotics, and thus, cases of TASS can develop as an outbreak. In this study, the fact that the patients were seen in clusters on 3 separate days led us to favor of TASS.
Although TASS and endophthalmitis may have similar clinical features, their management is completely different. The priority in endophthalmitis is to control the infection with intensive antimicrobial use. Whereas TASS develops as a sterile inflammatory reaction in the anterior chamber, the main treatment for TASS is topical corticosteroid administration.[16] However, ocular pressure elevation due to topical corticosteroid therapy should always be monitored. In addition, chronic trabeculitis or peripheral anterior synechia formation due to TASS may permanently damage the trabecular meshwork, leading to reduced trabecular outflow and secondary glaucoma.[10] In case of elevated ocular pressure, the use of prostaglandin analogs should be avoided to prevent an inflammatory reaction in the anterior chamber. Topical steroid was started in all of the cases in this study, and additional systemic steroid treatment was added to one patient with mild anterior vitiritis.
Although pain and hypopyon in favor of endophthalmitis in these cases cast doubt on us, the primary diagnosis was considered in favor of TASS due to the time of onset of symptoms and the occurrence of clusters of cases. However, for precautionary purposes, the patients were hospitalized, treated, and evaluated according to the clinical course in close follow-up. TASS, which is generally known to have a good prognosis, progressed well in the cases in this study and the inflammatory response regressed without any complications in all patients.
Conclusion
Encountering severe inflammation in the postoperative period in cataract surgery is an important source of fear for ocular surgeons. Both TASS and endophthalmitis are undesirable complications, and the similarity of their clinics and the completely different treatment approaches continue to be a challenge for clinicians. For this reason, in such a case, considering the characteristics of the symptoms and signs from multiple perspectives, the patient should be followed closely, and the treatment should be applied.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
- 1.Maier P, Birnbaum F, Böhringer D, Reinhard T. Toxic anterior segment syndrome following penetrating keratoplasty. Arch Ophthalmol. 2008;126:1677–81. doi: 10.1001/archopht.126.12.1677. [DOI] [PubMed] [Google Scholar]
- 2.Hernandez-Bogantes E, Navas A, Naranjo A, Amescua G, Graue-Hernandez EO, Flynn HW, Jr, et al. Toxic anterior segment syndrome:A review. Surv Ophthalmol. 2019;64:463–76. doi: 10.1016/j.survophthal.2019.01.009. [DOI] [PubMed] [Google Scholar]
- 3.Çakır B, Celik E, Aksoy NÖ, Bursalı Ö, Uçak T, Bozkurt E, et al. Toxic anterior segment syndrome after uncomplicated cataract surgery possibly associated with intracamaral use of cefuroxime. Clin Ophthalmol. 2015;9:493–7. doi: 10.2147/OPTH.S74249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Amigó A, Martinez-Sorribes P. Toxic intraocular syndrome. J Ophthalmic Vis Res. 2022;17:155–6. doi: 10.18502/jovr.v17i1.10184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Patel SB, Reddy NK, He YG. Toxic posterior segment syndrome after dropless cataract surgery with compounded triamcinolone-moxifloxacin. Retina. 2020;40:446–55. doi: 10.1097/IAE.0000000000002450. [DOI] [PubMed] [Google Scholar]
- 6.Simakurthy S, Kumar M, Jain H, Kanakamedala A, Gudimetla J. Silicone oil tamponade induced vasculitis- a rare manifestation of toxic posterior segment syndrome. Eur J Ophthalmol. 2023:11206721231187923. doi: 10.1177/11206721231187923. Epub ahead of print. [DOI] [PubMed] [Google Scholar]
- 7.Sahoo NK, Behera S, Narayanan R, Chhablani J. Toxic posterior segment syndrome presenting as occlusive retinal vasculitis following vitreoretinal surgery. J Curr Ophthalmol. 2021;33:345–8. doi: 10.4103/joco.joco_42_20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sengupta S, Chang DF, Gandhi R, Kenia H, Venkatesh R. Incidence and long-term outcomes of toxic anterior segment syndrome at Aravind Eye Hospital. J Cataract Refract Surg. 2011;37:1673–8. doi: 10.1016/j.jcrs.2011.03.053. [DOI] [PubMed] [Google Scholar]
- 9.Feng HL, Robbins CB, Fekrat S. A nine-year analysis of practice patterns, microbiologic yield, and clinical outcomes in cases of presumed infectious endophthalmitis. Ophthalmol Retina. 2020;4:555–9. doi: 10.1016/j.oret.2020.03.009. [DOI] [PubMed] [Google Scholar]
- 10.Shouchane-Blum K, Dotan A, Bahar I. The evolution of toxic anterior segment syndrome. Curr Opin Ophthalmol. 2019;30:50–5. doi: 10.1097/ICU.0000000000000540. [DOI] [PubMed] [Google Scholar]
- 11.Suzuki T, Ohashi Y, Oshika T, Goto H, Hirakata A, Fukushita K, et al. Outbreak of late-onset toxic anterior segment syndrome after implantation of one-piece intraocular lenses. Am J Ophthalmol. 2015;159:934–9.e2. doi: 10.1016/j.ajo.2015.01.023. [DOI] [PubMed] [Google Scholar]
- 12.Hernandez Da Mota SE, Luis Guerrero Naranjo J, Dalma Weiszhausz J, Velez Montoya R, Gonzalez Cortes JH. Acute postoperative infectious endophthalmitis:Infectious Eye Diseases - Recent Advances in Diagnosis and Treatment, IntechOpen. [[Last accessed on 2021 Oct 27]]. Available from:http://dx.doi.org/10.5772/intechopen.97545 .
- 13.O'Day DM, Smith RS, Gregg CR, Turnbull PC, Head WS, Ives JA, et al. The problem of Bacillus species infection with special emphasis on the virulence of Bacillus cereus. Ophthalmology. 1981;88:833–8. doi: 10.1016/s0161-6420(81)34960-4. [DOI] [PubMed] [Google Scholar]
- 14.Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013;19:227–34. doi: 10.1111/1469-0691.12118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gopal L, Vijaya L. Toxic anterior segment syndrome. Br J Ophthalmol. 2013;97:953. doi: 10.1136/bjophthalmol-2013-303146. [DOI] [PubMed] [Google Scholar]
- 16.Johnston J. Toxic anterior segment syndrome –More than sterility meets the eye. AORN J. 2006;84:969–84. doi: 10.1016/s0001-2092(06)63994-x. [DOI] [PubMed] [Google Scholar]


